Keywords
Clinical trialMedicineBaseline (sea)Sample size determinationInternal medicineStatistics
Affiliated Institutions
Related Publications
Statistical Problems in the Reporting of Clinical Trials
Reports of clinical trials often contain a wealth of data comparing treatments. This can lead to problems in interpretation, particularly when significance testing is used exten...
Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?
When Archie Cochrane reproached the medical profession for not having critical summaries of all randomised controlled trials, about 14 reports of trials were being published per...
RoB 2: a revised tool for assessing risk of bias in randomised trials
Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is t...
A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical Experts
Finding and analyzing all therapeutic trials in a given field has become such a difficult and specialized task that the clinical experts called on to summarize the evidence in a...
Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia
Background A recent review suggested an association between using unpublished scales in clinical trials and finding significant results. Aims To determine whether such an associ...
Publication Info
- Year
- 1990
- Type
- review
- Volume
- 335
- Issue
- 8682
- Pages
- 149-153
- Citations
- 496
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
496
OpenAlex
Cite This
Douglas G. Altman,
Caroline J Doré
(1990).
Randomisation and baseline comparisons in clinical trials.
The Lancet
, 335
(8682)
, 149-153.
https://doi.org/10.1016/0140-6736(90)90014-v
Identifiers
- DOI
- 10.1016/0140-6736(90)90014-v